<p>There is provided a combination product comprising a VEGFR tyrosine kinase inhibitor and a m TOR-selective kinase inhibitor, and methods for the production of an anti-cancer effect in a patient, which is accordingly useful in the treatment of cancer in a patient.</p>
申请公布号
WO2009104019(A1)
申请公布日期
2009.08.27
申请号
WO2009GB50167
申请日期
2009.02.20
申请人
ASTRAZENECA AB;ASTRAZENECA UK LIMITED;JUERGENSMEIER, JULIANE;SPEAKE, GEORGINA
